COMP <GO>
CRSP vs KOD // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
CRISPR Therapeutics AG (NASDAQ) VS. Kodiak Sciences Inc (NASDAQ) • 15-METRIC TALLY: CRSP 3
— KOD 7
■ METRIC PARITY
LAST: $49.99 (0.00%) • MKT CAP: $4.83B
options-implied-move
—
LAST: $98.89 (+1.30%) • MKT CAP: $6.14B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CRSP VS. KOD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CRSP | KOD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -30.60% | -35.00% | +4.40 | CRSP | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.59% | -2.16% | -4.43 | KOD | /fcf-yield <GO> |
| Operating Margin | -60.00% | -13.30% | -46.70 | KOD | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -13.00% | -47.00 | KOD | /net-margins <GO> |
| Revenue Growth (YoY) | -65.00% | 1.10% | -66.10 | KOD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.97 | 16.70 | -8.73 | KOD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 4/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.0 | 63.0 | -19.00 | KOD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.12 | 0.90 | +0.22 | CRSP | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.0x | 35.0x | -7.00 | CRSP | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.83B | $6.14B | -$1.30B | KOD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CRSP REV | KOD REV | CRSP GROSS % | KOD GROSS % | CRSP FCF | KOD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.5M | $656.3M | — | — | -$345.9M | -$136.5M |
| FY 2024 | $37.3M | $523.2M | — | — | -$144.7M | -$117.7M |
| FY 2023 | $371.2M | $776.5M | — | — | -$277.1M | -$154.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CRSP // BETA 1.12
KOD // BETA 0.90